![Craig Paterson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Craig Paterson
Geen lopende functies
Vermogen: 404 340 $ op 31-05-2024
Profiel
Momenteel is Craig Paterson Chief Medical Officer bij Allakos, Inc. In het verleden was hij Chief Medical Officer bij Endo International Plc en Senior VP-Medical & Clinical Development bij Salix Pharmaceuticals Ltd. Hij behaalde een diploma aan de McMaster University en een MBA aan de University of Tennessee.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
ALLAKOS, INC.
0.37% | 04-12-2023 | 323 472 ( 0.37% ) | 404 340 $ | 31-05-2024 |
Eerdere bekende functies van Craig Paterson
Bedrijven | Functie | Einde |
---|---|---|
ALLAKOS INC. | Hoofd Techniek/Wetenschap/O&O | 09-02-2024 |
UMass Chan Medical School | Corporate Officer/Principal | - |
Vivelix Pharmaceuticalsc Corp. | Oprichter | - |
ENDO INTERNATIONAL PLC | Hoofd Techniek/Wetenschap/O&O | - |
SALIX PHARMACEUTICALS, LTD. | Corporate Officer/Principal | - |
Opleiding van Craig Paterson
McMaster University | Graduate Degree |
University of Tennessee | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ALLAKOS INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Salix Pharmaceuticals Ltd.
![]() Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
Endo International Plc
![]() Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Vivelix Pharmaceuticalsc Corp. |